mRNA

R&D

GSK on COVID and vaccine development: the pharmaphorum podca...

In the latest episode of the pharmaphorum podcast Dominic Tyer speaks with GlaxoSmithKline’s Philip Cruz about the discovery and commercialisation of new vaccines in the light of the pandem

News

Moderna seeks COVID vaccine okay as data backs 94% efficacy

Moderna has said it will file for US, European and UK emergency approval of its coronavirus vaccine straight away, after reporting updated phase 3 results for the shot.

Events

Harnessing TIGIT Checkpoint Inhibitor Therapies as the Next Pillar of Frontline Cancer Treatments (1)

Partner Content

3rd RNA-Targeted Drug Discovery Summit

Expanding RNA Druggability with Small Molecules

News

Expert 'optimistic' over COVID-19 vaccines after Moderna dat...

There are reasons to be optimistic over the cutting-edge mRNA vaccines being developed to end the COVID-19 pandemic, according to an expert in the field.

News

Pfizer invests in mRNA vaccine powerhouse BioNTech

Pfizer is to pay German company BioNTech up to $425m for a multi-year collaboration in the development of more effective influenza vaccines, joining other pharma giants in a promising mRNA-

Partner Content